Inventor · disambiguated record
Snahel Patel
Also filed as: PATEL SNAHEL
33 granted patents·12 pending applications·97 citations·filing 2013–2025
96Inventor score
Files withGENENTECH INC35TENAYA THERAPEUTICS INC4FRONTIER MEDICINES CORP3BAIR KENNETH W1FORMA TM LLC1
Top patents by PatentIndex Score
45 records- 0194US11926622B2Fluoroalkyl-oxadiazoles and uses thereofTENAYA THERAPEUTICS INC·Filed 2022·Granted Mar 12, 2024·3 cites·20 claims
- 0294US11634436B2Pyridine lactam compounds and methods of use thereofGENENTECH INC·Filed 2020·Granted Apr 25, 2023·3 cites·22 claims
- 0394US11578066B1Fluoroalkyl-oxadiazoles and uses thereofTENAYA THERAPEUTICS INC·Filed 2022·Granted Feb 14, 2023·3 cites·28 claims
- 0494US9822129B2Amido spirocyclic amide and sulfonamide derivativesGENENTECH INC·Filed 2013·Granted Nov 21, 2017·26 cites·35 claims
- 0593US10988459B2Bicyclic lactams and methods of use thereofGENENTECH INC·Filed 2016·Granted Apr 27, 2021·7 cites·31 claims
- 0691US11485745B2Amido spirocyclic amide and sulfonamide derivativesVALO HEALTH INC·Filed 2020·Granted Nov 1, 2022·2 cites·19 claims
- 0791US11072607B2Inhibitors of RIP1 kinase and methods of use thereofGENENTECH INC·Filed 2017·Granted Jul 27, 2021·6 cites·3 claims
- 0891US11071721B2Bicyclic amide compounds and methods of use thereofGENENTECH INC·Filed 2017·Granted Jul 27, 2021·4 cites·17 claims
- 0989US11098058B2Bicyclic ketone compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Aug 24, 2021·3 cites·27 claims
- 1089US10730889B2Amido spirocyclic amide and sulfonamide derivativesFORMA TM LLC·Filed 2018·Granted Aug 4, 2020·6 cites·16 claims
- 1189US9266862B2Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2014·Granted Feb 23, 2016·9 cites·55 claims
- 1287US10028954B2Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2016·Granted Jul 24, 2018·4 cites·60 claims
- 1385US9868720B2C-linked heterocycloaklyl substituted pyrimidines and their usesGENENTECH INC·Filed 2015·Granted Jan 16, 2018·6 cites·20 claims
- 1483US11072617B2Bicyclic sulfones and sulfoxides and methods of use thereofGENENTECH INC·Filed 2018·Granted Jul 27, 2021·2 cites·35 claims
- 1583US10947226B2Bicyclic pyridone lactams and methods of use thereofGENENTECH INC·Filed 2019·Granted Mar 16, 2021·3 cites·23 claims
- 1680US10010549B2Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2015·Granted Jul 3, 2018·2 cites·10 claims
- 1780US9365583B2Substituted pyrazoles and uses thereofGENENTECH INC·Filed 2014·Granted Jun 14, 2016·3 cites·40 claims
- 1879US12312345B2Fluoroalkyl-oxadiazoles and uses thereofTENAYA THERAPEUTICS INC·Filed 2023·Granted May 27, 2025·0 cites·32 claims
- 1978USRE47848EBiheteroaryl compounds and uses thereofGENENTECH INC·Filed 2018·Granted Feb 11, 2020·1 cites·56 claims
- 2077US2020171029A1Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 2174US2024300974A1Bicyclic ketone compounds and methods of use thereofGENENTECH INC·Filed 2023·Application pending·0 cites
- 2273US11129832B2Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2019·Granted Sep 28, 2021·0 cites·27 claims
- 2373US9873709B2Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2017·Granted Jan 23, 2018·1 cites·14 claims
- 2472US9399636B2Substituted dipyridylamines and uses thereofGENENTECH INC·Filed 2014·Granted Jul 26, 2016·2 cites·17 claims
- 2571US10028942B23-substituted pyrazoles and uses thereofGENENTECH INC·Filed 2016·Granted Jul 24, 2018·1 cites·69 claims
- 2668US2025282788A1Bicyclic ketone compounds and methods of use thereofGENENTECH INC·Filed 2025·Application pending·0 cites
- 2765US12344612B2Bicyclic ketone compounds and methods of use thereofGENENTECH INC·Filed 2021·Granted Jul 1, 2025·0 cites·12 claims
- 2865US12281101B2Bicyclic lactams and methods of use thereofGENENTECH INC·Filed 2021·Granted Apr 22, 2025·0 cites·15 claims
- 2965US12139482B2Bicyclic pyridone lactams and methods of use thereofGENENTECH INC·Filed 2021·Granted Nov 12, 2024·0 cites·21 claims
- 3065US11834461B2Bicyclic ketone compounds and methods of use thereofGENENTECH INC·Filed 2021·Granted Dec 5, 2023·0 cites·11 claims
- 3165US11607396B2Bicyclic amide compounds and methods of use thereofGENENTECH INC·Filed 2021·Granted Mar 21, 2023·0 cites·16 claims
- 3265US2018117044A1Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 3364US12338241B2Bicyclic sulfones and sulfoxides and methods of use thereofGENENTECH INC·Filed 2021·Granted Jun 24, 2025·0 cites·21 claims
- 3464US12291539B2KRAS G12C inhibitorsFRONTIER MEDICINES CORP·Filed 2024·Granted May 6, 2025·0 cites·29 claims
- 3564US2018133219A1Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 3660US2019233441A1Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 3759US2025340548A1Kras g12c inhibitorsFRONTIER MEDICINES CORP·Filed 2022·Application pending·0 cites
- 3857US2018298033A1Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 3956US2023123856A15-fluoronicotinamide derivatives and uses thereofTENAYA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4056US2017216262A1Amido spirocyclic amide and sulfonamide derivativesBAIR KENNETH W·Filed 2017·Application pending·0 cites
- 4152US2016185780A1Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2016·Application pending·0 cites
- 4248US2025129103A1Methods for treatment of cancerFRONTIER MEDICINES CORP·Filed 2023·Application pending·0 cites
- 4343US11673892B2Bicyclic compounds for use as RIP1 kinase inhibitorsGENENTECH INC·Filed 2020·Granted Jun 13, 2023·0 cites·29 claims
- 4442US9550777B23-substituted pyrazoles and use as DLK inhibitorsGENENTECH INC·Filed 2015·Granted Jan 24, 2017·0 cites·30 claims
- 4541US10131675B2Tricyclic DLK inhibitors and uses thereofGENENTECH INC·Filed 2017·Granted Nov 20, 2018·0 cites·34 claims
Join the waitlist — get patent alerts
Get an alert when Snahel Patel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →